Adachi Y, Aleksic B, Ozaki N (2010) Comparison of pharmacological profiles of serotonin norepinephrine reuptake inhibitors. Clinical Neuropsychopharmacology and Therapeutics 1:10–15. https://doi.org/10.5234/cnpt.1.10

Article  Google Scholar 

Alcántara AG (1999) A possible dopaminergic mechanism in the serotonergic antidepressant-induced sexual dysfunctions. J Sex Marital Ther 25(2):125–129. https://doi.org/10.1080/00926239908403985

Article  PubMed  Google Scholar 

Alvarez Silva A, Fernández-Guasti A (2020) Does the antidepressant-like effect of mirtazapine and venlafaxine differ between male and female rats? Salud Mental, 43(1), Article 1. https://doi.org/10.17711/SM.0185-3325.2020.002

Alvarez Silva A, Fernández-Guasti A (2019) The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior. Pharmacol Biochem Behav 187:172817. https://doi.org/10.1016/j.pbb.2019.172817

Article  CAS  PubMed  Google Scholar 

Atmaca M, Korkmaz S, Topuz M, Mermi O (2011) Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retrospective investigation. Psychiatry Investig 8(1):55–57. https://doi.org/10.4306/pi.2011.8.1.55

Article  CAS  PubMed  Google Scholar 

Aydemir O, Deveci A, Taskin E (2009) Mirtazapine combination in treatment resistant major depressive disorder: a retrospective evaluation of six weeks. Klinik Psikofarmakoloji Bülteni, Cilt: 19, Say›: 4, 2009 / Bulletin of Clinical Psychopharmacology, Vol: 19, N: 4, 2009

Barbar S, Khalili M, Mahdavi S, Modarresi Chahardehi A. (2022). The effect of mirtazapine on reducing chronic stress in male rats. Int Clin Neurosci J 9:e21. https://journals.sbmu.ac.ir/neuroscience/article/view/37860

Beach FA (1956) Characteristics of masculine “sex drive.” In: Jones MR (ed) Nebraska symposium on motivation. Lincoln, University Nebraska press, pp 1–32

Google Scholar 

Benelli A, Frigeri C, Bertolini A, Genedani S (2004) Influence of mirtazapine on the sexual behavior of male rats. Psychopharmacology 171(3):250–258. https://doi.org/10.1007/s00213-003-1591-y

Article  CAS  PubMed  Google Scholar 

Berlanga C, Flores-Ramos M (2006) Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. J Affect Disord 95(1):119–123. https://doi.org/10.1016/j.jad.2006.04.029

Bijlsma EY, Chan JSW, Olivier B, Veening JG, Millan MJ, Waldinger MD, Oosting RS (2014) Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release? Pharmacol Biochem Behav 121:88–101. https://doi.org/10.1016/j.pbb.2013.10.004

Article  CAS  PubMed  Google Scholar 

Carpenter LL, Yasmin S, Price LH (2002) A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry 51(2):183–188. https://doi.org/10.1016/S0006-3223(01)01262-8

Article  CAS  PubMed  Google Scholar 

Casilla-Lennon MM, Meltzer-Brody S, Steiner AZ (2016) The effect of antidepressants on fertility. Am J Obstet Gynecol 215(3):314.e1-314.e5. https://doi.org/10.1016/j.ajog.2016.01.170

Article  CAS  PubMed  Google Scholar 

Cheeta S, Ruigt G, van Proosdij J, Willner P (1997) Changes in sleep architecture following chronic mild stress. Biol Psychiatry 41(4):419–427. https://doi.org/10.1016/S0006-3223(96)00058-3

Article  CAS  PubMed  Google Scholar 

Clayton AH (2003) Sexual function and dysfunction in women. Psychiatr Clin North Am 26(3):673–682. https://doi.org/10.1016/S0193-953X(03)00043-1

Article  PubMed  Google Scholar 

Clayton AH, Croft HA, Handiwala L (2014) Antidepressants and sexual dysfunction: mechanisms and clinical implications. Postgrad Med 126(2):91–99. https://doi.org/10.3810/pgm.2014.03.2744

Article  PubMed  Google Scholar 

de la Gándara J, Rojo JE, Ros S, Agüera L, de Pedro JM (2005) Neuropharmacological basis of combining antidepressants. Acta Psychiatr Scand 112(s428):11–13. https://doi.org/10.1111/j.1600-0447.2005.00675.x

Article  Google Scholar 

Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121(1):66–72. https://doi.org/10.1007/BF02245592

Article  CAS  PubMed  Google Scholar 

Domingues RR, Wiltbank MC, Hernandez LL (2023) The antidepressant fluoxetine (Prozac®) modulates estrogen signaling in the uterus and alters estrous cycles in mice. Mol Cell Endocrinol 559:111783. https://doi.org/10.1016/j.mce.2022.111783

Article  CAS  PubMed  Google Scholar 

Duman CH (2010) Chapter One—Models of Depression. In Litwack G (ed) Vitamins & Hormones Vol. 82. Academic Press. pp. 1–21. https://doi.org/10.1016/S0083-6729(10)82001-1

Erskine MS (1989) Solicitation behavior in the estrous female rat: A review. Horm Behav 23(4):473–502. https://doi.org/10.1016/0018-506X(89)90037-8

Article  CAS  PubMed  Google Scholar 

Estrada-Camarena E, Rivera NM, Berlanga C, Fernández-Guasti A (2008) Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test. Psychopharmacology 201(3):351–360. https://doi.org/10.1007/s00213-008-1291-8

Article  CAS  PubMed  Google Scholar 

Farah A (1999) Relief of SSRI-induced sexual dysfunction with mirtazapine treatment. J Clin Psychiatry 60:260–261. https://doi.org/10.4088/JCP.v60n0412a

Article  CAS  PubMed  Google Scholar 

Frackiewicz EJ, Sramek JJ, Cutler NR (2000) Gender Differences in Depression and Antidepressant Pharmacokinetics and Adverse Events. Ann Pharmacother 34(1):80–88. https://doi.org/10.1345/aph.18465

Article  CAS  PubMed  Google Scholar 

Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G (2019) Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 6(7):601–609. https://doi.org/10.1016/S2215-0366(19)30217-2

Article  PubMed  PubMed Central  Google Scholar 

Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM (2002) Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. J Clin Psychiatry 63(7):577–584. https://doi.org/10.4088/JCP.v63n0707

Article  CAS  PubMed  Google Scholar 

Hardy D, Debold JF (1971) Effects of mounts without intromission upon the behavior of female rats during the onset of estrogen-induced heat. Physiol Behav 7(4):643–645. https://doi.org/10.1016/0031-9384(71)90120-X

Article  CAS  PubMed  Google Scholar 

Herrera-Pérez JJ, Martínez-Mota L, Fernández-Guasti A (2008) Aging increases the susceptibility to develop anhedonia in male rats. Prog Neuropsychopharmacol Biol Psychiatry 32(8):1798–1803. https://doi.org/10.1016/j.pnpbp.2008.07.020

Article  PubMed  Google Scholar 

Higgins A, Nash M, Lynch AM (2010) Antidepressant-associated sexual dysfunction: Impact, effects, and treatment. Drug Healthc Patient Saf 2:141–150. https://doi.org/10.2147/DHPS.S7634

Article  PubMed  PubMed Central  Google Scholar 

Hull EM, Muschamp JW, Sato S (2004) Dopamine and serotonin: Influences on male sexual behavior. Physiol Behav 83(2):291–307. https://doi.org/10.1016/j.physbeh.2004.08.018

Article  CAS  PubMed  Google Scholar 

Kamal S (2013) Modulating role of mirtazapine on concentrations of both glutamate and gaba in nucleus accumbens of chronic mild stressed albino rats. J Neurol Disord 1:110. https://doi.org/10.4172/2329-6895.1000110

Article  Google Scholar 

Keers R, Aitchison KJ (2010) Gender differences in antidepressant drug response. Int Rev Psychiatry 22(5):485–500. https://doi.org/10.3109/09540261.2010.496448

Article  PubMed  Google Scholar 

Kennedy SH, Rizvi S (2009) Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 29(2):157. https://doi.org/10.1097/JCP.0b013e31819c76e9

Article  CAS  PubMed  Google Scholar 

Kessler DS, MacNeill SJ, Tallon D, Lewis G, Peters TJ, Hollingworth W, Round J, Burns A, Chew-Graham CA, Anderson IM, Shepherd T, Campbell J, Dickens CM, Carter M, Jenkinson C, Macleod U, Gibson H, Davies S (2018) Wiles NJ (2018) Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: Phase III randomised placebo controlled trial (MIR). BMJ 363:k4218. https://doi.org/10.1136/bmj.k4218

Article